Tag: Mathew Erick

Biocon Biologics debuts biosimilar HULIO in US market

businessnewstoday- July 4, 2023

In a significant development for healthcare accessibility, Biocon Biologics Ltd (BBL), a subsidiary of Biocon, announced the availability of its biosimilar injection, HULIO (adalimumab-fkjp), in ... Read More